Aztech Sciences Competitors and Similar CompaniesClear all
CanSino Biologics's competitors and similar companies include IRBM and FibroGen.
 CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. | ||
Founding Date | Founding Date 2009 | Founding Date 1990 | Founding Date 1993 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Tianjin, CN HQ | Locations Rome, IT HQ | Locations San Francisco, US HQ |
Employees | Employees 1,10526% decrease | Employees 2931% decrease | Employees 53115% increase |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) €30.4m (Y, 2022) | Revenue (est.) $6.4m (FY, 2025) |
Cost of goods | Cost of goods ¥81.4m (FY, 2025) | Cost of goods N/A | Cost of goods $556k (FY, 2025) |
Gross profit | Gross profit ¥1.1b (FY, 2025) | Gross profit N/A | Gross profit $5.9m (FY, 2025) |
Net income | Net income ¥27.9m (FY, 2025) | Net income N/A | Net income $183.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
IRBM
HQ
Rome, IT
Employees
293↓ 1% decrease
IRBM is a company that provides drug discovery and preclinical development services.
View companyFibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View company